clioquinol has been researched along with Dysesthesia in 9 studies
Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The onset of all manifestations (except toxic encephalopathy) was usually subacute, with subsequent partial recovery." | 1.26 | Neurotoxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan. ( Baumgartner, G; Gawel, MJ; Kaeser, HE; Pallis, CA; Rose, FC; Schaumburg, HH; Thomas, PK; Wadia, NH, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devoize, JL | 1 |
| Calmette, I | 1 |
| Lavarenne, J | 1 |
| Tournilhac, M | 1 |
| Mamoli, B | 1 |
| Thaler, A | 1 |
| Heilig, P | 1 |
| Siakos, G | 1 |
| Froissart, M | 1 |
| Morcamp, D | 1 |
| Mizon, JP | 1 |
| Baumgartner, G | 1 |
| Gawel, MJ | 1 |
| Kaeser, HE | 1 |
| Pallis, CA | 1 |
| Rose, FC | 1 |
| Schaumburg, HH | 1 |
| Thomas, PK | 1 |
| Wadia, NH | 1 |
| Osterman, PO | 1 |
| Spillane, JD | 1 |
| Weyers, H | 1 |
| Gendre, JP | 1 |
| Barbanel, C | 1 |
| Degos, JD | 1 |
| Le Quintrec, Y | 1 |
| Cohen, D | 1 |
| Streifler, M | 1 |
9 other studies available for clioquinol and Dysesthesia
| Article | Year |
|---|---|
[Persistence of the neurologic risk of clioquinol].
Topics: Clioquinol; Female; Humans; Hydroxyquinolines; Middle Aged; Paresthesia; Vision Disorders | 1983 |
[Subacute myelo-optic-neuropathy (S.M.O.N.) following treatment with clioquinol (author's transl)].
Topics: Abdomen, Acute; Aged; Clioquinol; Colostomy; Electromyography; Extremities; Female; Humans; Male; My | 1975 |
[Letter: Sensitivo-motor myelon-neuropathy after chloroidoquinone absorption].
Topics: Aged; Clioquinol; Colitis; Female; Humans; Leg; Myelitis; Neuritis; Paresthesia | 1976 |
Neurotoxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan.
Topics: Adolescent; Adult; Aged; Brain Diseases; Child; Child, Preschool; Clioquinol; Dose-Response Relation | 1979 |
Myelopathy after clioquinol treatment.
Topics: Abdomen; Adult; Clioquinol; Humans; Male; Myelitis; Nervous System Diseases; Neurologic Manifestatio | 1971 |
S.M.O.N.
Topics: Abdomen; Adult; Clioquinol; Diarrhea; Female; Humans; Myelitis; Optic Neuritis; Pain; Paresthesia | 1972 |
[Nerve and eye damage caused by oxyquinoline].
Topics: Clioquinol; Paresthesia; Vision Disorders | 1972 |
[Serious sensory-motor neuropathy. A case of renal failure following clioquinol absorption].
Topics: Abdomen; Autopsy; Clioquinol; Demyelinating Diseases; Drug Tolerance; Electromyography; Humans; Kidn | 1974 |
[Hydroxyquinoline derivatives and the nervous system].
Topics: Acrodermatitis; Amebiasis; Child; Chloroquine; Clioquinol; Humans; Male; Paresthesia; Peripheral Ner | 1972 |